Perbedaan Charlie Hospital Semarang Tbk. dan Solusi Bangun Indonesia Tbk.: Charlie Hospital Semarang Tbk. diperdagangkan di Rp430 (kapitalisasi pasar 1,11 T, volume 24 jam 25,61 jt), sedangkan Solusi Bangun Indonesia Tbk. diperdagangkan di Rp775 (kapitalisasi pasar 6,99 T). Perbedaan utamanya: Solusi Bangun Indonesia Tbk. jauh lebih besar — sekitar 6,3× kapitalisasi pasar Charlie Hospital Semarang Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| RSCH | SMCB | |
|---|---|---|
Kapitalisasi Pasar | 1,11 T | 6,99 T |
Volume | 25,61 jt | — |
Lot | 256,07 rb | — |
Perputaran | 10,76 M | — |
Harga Rata-rata | 420,16 | — |
Nilai Transaksi | 10,76 M | — |
Harga Ekuilibrium Indikatif | 430 | — |
Volume Ekuilibrium Indikatif | 1,46 rb | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Selengkapnya di halaman RSCH →PT Holcim Indonesia Tbk (the Company) was originally a joint venture between a subsidiary of Kaiser Cement and Gypsum Corp. and PT Semen Gresik. Founded in 1971, the company owns a factory in Narogong, West Java, with an annual capacity of 3 million tons. The Company changed its foreign capital investment status (PMA) to domestic capital investment (PMDN) based on the approval from Chairman of Capital Investment Coordinating Board No. 17/V/1988 dated November 19, 1988. Effective January 1, 2006, the Company changed its name from PT Semen Cibinong Tbk. to PT Holcim Indonesia Tbk.
Selengkapnya di halaman SMCB →